Pharma Earnings: The PILL to CURE Market Troubles?
While October’s troubles are still working their way through the markets, one thing that has managed to brighten the disposition of some…
PILL
A Potent Pharmaceuticals ETF
Healthcare ETFs have been displaying positive momentum. Traders looking to bolster that healthcare momentum profile can consider leveraged ETFs, such as the…
Pharma, Biotech Bull ETFs Leading the Charge
The rising prices of drug treatments, more dependence on immuno-oncology and mergers focused on mid-sized biotech company acquisitions are just a few…
Direxion Resuscitates Leveraged Pharmaceutical ETF
Direxion has revived one of its previously shuttered leveraged ETF ideas and increased the stakes on its original design. On Wednesday, Direxion…
Drug Makers, Pharma ETFs Face a Tough Earnings Season
The healthcare sector has been lackluster this earnings season, and without supporting factors such as price increases or increased mergers and acquisitions…
Direxion Debuts Double Leveraged Cyber Security, Pharmaceuticals ETFs
Direxion, the second-largest issuer of inverse and leveraged exchange traded funds, is making another big addition to its leveraged stable today with…